These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 194618)

  • 1. Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Br J Cancer; 1977 Jun; 35(6):834-43. PubMed ID: 194618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cell-mediated cytotoxicity to chemically induced rat tumours by soluble tumour and embryo cell extracts.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1976 Jan; 17(1):129-37. PubMed ID: 175021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated cytotoxicity to chemically-induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1975 Oct; 16(4):593-606. PubMed ID: 170224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
    Steele G; Sjögren HO; Lannerstad O; Stadenberg I
    Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the microcytotoxicity test. I. Evidence that the effects of normal lymphoid cells on tumour cell growth in microtest plates may be caused by non-immunological modifications of the culture medium.
    Brooks CG; Rees RC; Baldwin RW
    Int J Cancer; 1976 Dec; 18(6):778-86. PubMed ID: 186418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of embryonic antigens associated with chemically induced rat tumours.
    Baldwin RW; Glaves D; Vose BM
    Int J Cancer; 1974 Jan; 13(1):135-42. PubMed ID: 4361915
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic and in-situ natural killer activity in tumour-bearing rats.
    Moore K; Moore M
    Br J Cancer; 1979 Jun; 39(6):636-47. PubMed ID: 375965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
    Greenberg AH; Shen L; Medley G
    Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells.
    Holden HT; Oldham RK; Ortaldo JR; Herberman RB
    J Natl Cancer Inst; 1977 Mar; 58(3):611-22. PubMed ID: 839557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous development of cytotoxic activity in cultured lymphnode cells from tumour-bearing rats.
    Robins RA; Rees RC; Brooks CG; Baldwin RW
    Br J Cancer; 1979 Jun; 39(6):659-66. PubMed ID: 109111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.
    Burton R; Thompson J; Warner NL
    J Immunol Methods; 1975; 8(1-2):133-49. PubMed ID: 807654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours.
    Baldwin RW; Glaves D; Vose BM
    Br J Cancer; 1974 Jan; 29(1):1-10. PubMed ID: 4362448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour rejection in rats sensitized to embryonic tissue. I. Rejection of tumour cells implanted s.c. and detection of cytotoxic lymphoid cells.
    Shah LP; Rees RC; Baldwin RW
    Br J Cancer; 1976 Jun; 33(6):577-83. PubMed ID: 181040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR; Baldwin RW
    Int J Cancer; 1977 Aug; 20(2):284-91. PubMed ID: 197028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subpopulations of multiparous rat lymph-node cells cytotoxic for rat tumour cells and capable of suppressing cytotoxicity in vitro.
    Rees RC; Bray J; Robins RA; Baldwin RW
    Int J Cancer; 1975 May; 15(5):762-72. PubMed ID: 166946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in sensitivity of the microcytotoxicity assay by T cell growth factor (IL-2)-containing preparations.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1984; 30(1):43-9. PubMed ID: 6609090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC; Nunn ME; Park JY; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-specific antibody neutralization of factors in rat hepatoma-bearer serum which abrogate lymph-node-cell cytotoxicity.
    Robins RA; Baldwin RW
    Int J Cancer; 1974 Nov; 14(5):589-97. PubMed ID: 4376528
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumour specific and embryonic antigen expression of chemically induced rat tumours.
    Baldwin RW; Glaves D; Pimm MV; Vose BM
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):715-28. PubMed ID: 4340543
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of the proline assay in the study of anti-MSV cell-mediated immune reactions.
    Henin Y; Gomard E; Gisselbrecht S; Levy JP
    Br J Cancer; 1979 Jan; 39(1):51-63. PubMed ID: 215185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.